HOME >> BIOLOGY >> NEWS
Small gene changes in some leukemia patients may explain varying responses to chemotherapy

A new study provides evidence that may explain why some patients with chronic lymphocytic leukemia (CLL) are resistant to chemotherapy and have a shorter survival time and may identify a potential new target for treating the disease. Patients who had an insertion in the promoter region of a gene that regulates apoptosis, or programmed cell death, were more likely to have a poor response to chemotherapy and to have a rapid progression of the disease, according to the study, which is published in the May 5 issue of the Journal of the National Cancer Institute.

CLL is the most common form of leukemia in the United States: about 12,000 new cases are diagnosed each year. Unlike most cancers that occur because cells divide uncontrollably, CLL is caused primarily by defective apoptosis. Cells live an unnaturally long time and fail to die when they should. Patients diagnosed with CLL can live for months or years and can have varying responses to chemotherapy, although researchers do not know why this is the case or how to predict a patient's prognosis.

Increased levels of a protein called Mcl-1 have previously been associated with a lack of response to chemotherapy in CLL patients. To explore the mechanisms that might be responsible for these increased levels, Anurag Saxena, M.D., of the University of Saskatchewan and the Royal University Hospital in Saskatoon, Saskatchewan, Canada, and colleagues sequenced the MCL-1 gene from 58 CLL patients and 18 control subjects. They also measured expression levels of MCL-1 mRNA and Mcl-1 protein.

The researchers found insertions of 6 or 18 nucleotides in the promoter region of the MCL-1 gene in 17 of 58 CLL patients and in none of the controls. The insertions were all found in the same site in the promoter, in a region that contains binding sites for several transcription factors. Transcription factors are proteins that initiate or regulate the transcription of DNA into mRNA. Patients with the insertion
'"/>

Contact: Sarah L. Zielinski
jncimedia@oupjournals.org
301-841-1287
Journal of the National Cancer Institute
4-May-2004


Page: 1 2

Related biology news :

1. Small, Smac-like molecule encourages death of cancer cells
2. Small animal imaging gives cancer clues
3. Small RNA surmounts large cancer problem
4. Small, cold, & hungry: Ultra-small microbes from 120,000-year-old glacier ice sample
5. Small trial shows daclizumab add-on therapy improves MS outcome
6. Small amounts of alcohol or anesthetics may damage the developing brain
7. Smallpox in 50-year-old tissues detected by integrated diagnostics approach
8. Small-molecule inhibitors of anthrax lethal factor identified
9. Smallpox in Europe selected for genetic mutation that confers resistance to HIV infection
10. Small-molecule inhibitors of botulinum neurotoxin identified
11. Smallest whirlpools can pack stunningly strong force

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/14/2019)... ... ... Molecular diagnostics segment is the fastest-growing segment within the global IVD market. The ... are expected to drive the growth are infectious diseases, cancer, and transplant diagnostics. ... The World Molecular Diagnostics Market, 8th Edition . , The discovery of the structure ...
(Date:6/13/2019)... ... June 13, 2019 , ... Global ... exclusively serving the end-to-end clinical and ancillary supply chain management needs of large- ... medical research organizations, today announced it will sponsor a summer education program offered ...
(Date:6/11/2019)... ... June 10, 2019 , ... Improved Pharma LLC announces the publication ... of AAPS PharmSciTech. The article was published online on April 29th, 2019. The authors ... with Xiaoming Sean Chen of Purdue University. , The article is the most recent ...
Breaking Biology News(10 mins):
(Date:6/11/2019)... ... June 10, 2019 , ... Thought Technology Ltd is ... of Biofeedback Tech Ltd as its authorised distributor for the UK ... many therapeutic treatments and clinical assessment protocols to treat stress related disorders as ...
(Date:6/11/2019)... ... June 10, 2019 , ... DeepDyve and ... journals to DeepDyve’s rental service for peer-reviewed journals. , IOPP’s portfolio represents ... than 20 million articles, sourced from more than 15,000 journals. , “By partnering ...
(Date:6/11/2019)... ... June 11, 2019 , ... Veterinary Regenerative ... Inc. (PSC) , has announced that their GMP facility for cell production is ... for manufacturing. This is an important milestone for VetStem as it expands ...
(Date:6/6/2019)... ... June 05, 2019 , ... WCCT Global, Inc ... device industries, announced today that they will be receiving 3 awards at the 2019 ... WCCT received 2 awards in the categories of overall Quality and Compatibility (Access to ...
Breaking Biology Technology:
Cached News: